235 related articles for article (PubMed ID: 28436621)
1. Risk factors for mortality before age 18 years in cystic fibrosis.
McColley SA; Schechter MS; Morgan WJ; Pasta DJ; Craib ML; Konstan MW
Pediatr Pulmonol; 2017 Jul; 52(7):909-915. PubMed ID: 28436621
[TBL] [Abstract][Full Text] [Related]
2. Case-mix adjustment for evaluation of mortality in cystic fibrosis.
O'Connor GT; Quinton HB; Kahn R; Robichaud P; Maddock J; Lever T; Detzer M; Brooks JG;
Pediatr Pulmonol; 2002 Feb; 33(2):99-105. PubMed ID: 11802245
[TBL] [Abstract][Full Text] [Related]
3. Early childhood lung function is a stronger predictor of adolescent lung function in cystic fibrosis than early Pseudomonas aeruginosa infection.
Pittman JE; Noah H; Calloway HE; Davis SD; Leigh MW; Drumm M; Sagel SD; Accurso FJ; Knowles MR; Sontag MK
PLoS One; 2017; 12(5):e0177215. PubMed ID: 28505188
[TBL] [Abstract][Full Text] [Related]
4. [Italian Cystic Fibrosis Register - Report 2010].
Amato A; Ferrigno L; Salvatore M; Toccaceli V;
Epidemiol Prev; 2016; 40(2 Suppl 2):1-47. PubMed ID: 27291389
[TBL] [Abstract][Full Text] [Related]
5. Pulmonary outcome prediction (POP) tools for cystic fibrosis patients.
VanDevanter DR; Wagener JS; Pasta DJ; Elkin E; Jacobs JR; Morgan WJ; Konstan MW
Pediatr Pulmonol; 2010 Dec; 45(12):1156-66. PubMed ID: 20717915
[TBL] [Abstract][Full Text] [Related]
6. CFTR genotype as a predictor of prognosis in cystic fibrosis.
McKone EF; Goss CH; Aitken ML
Chest; 2006 Nov; 130(5):1441-7. PubMed ID: 17099022
[TBL] [Abstract][Full Text] [Related]
7. The determinants of survival among adults with cystic fibrosis-a cohort study.
Durda-Masny M; Goździk-Spychalska J; John A; Czaiński W; Stróżewska W; Pawłowska N; Wlizło J; Batura-Gabryel H; Szwed A
J Physiol Anthropol; 2021 Nov; 40(1):19. PubMed ID: 34749804
[TBL] [Abstract][Full Text] [Related]
8. [Italian Cystic Fibrosis Registry (ICFR). Report 2015-2016].
Giordani B; Amato A; Majo F; Ferrari G; Quattrucci S; Minicucci L; Padoan R; Floridia G; Salvatore D; Carnovale V; Puppo Fornaro G; Taruscio D; Salvatore M;
Epidemiol Prev; 2019; 43(4S1):1-36. PubMed ID: 31370382
[TBL] [Abstract][Full Text] [Related]
9. Up-to-date and projected estimates of survival for people with cystic fibrosis using baseline characteristics: A longitudinal study using UK patient registry data.
Keogh RH; Szczesniak R; Taylor-Robinson D; Bilton D
J Cyst Fibros; 2018 Mar; 17(2):218-227. PubMed ID: 29311001
[TBL] [Abstract][Full Text] [Related]
10. CFTR genotype and clinical outcomes of adult patients carried as cystic fibrosis disease.
Bonadia LC; de Lima Marson FA; Ribeiro JD; Paschoal IA; Pereira MC; Ribeiro AF; Bertuzzo CS
Gene; 2014 May; 540(2):183-90. PubMed ID: 24583165
[TBL] [Abstract][Full Text] [Related]
11. Baseline characteristics and factors associated with nutritional and pulmonary status at enrollment in the cystic fibrosis EPIC observational cohort.
Rosenfeld M; Emerson J; McNamara S; Joubran K; Retsch-Bogart G; Graff GR; Gutierrez HH; Kanga JF; Lahiri T; Noyes B; Ramsey B; Ren CL; Schechter M; Morgan W; Gibson RL;
Pediatr Pulmonol; 2010 Sep; 45(9):934-44. PubMed ID: 20597081
[TBL] [Abstract][Full Text] [Related]
12. European Epidemiologic Registry of Cystic Fibrosis (ERCF): comparison of major disease manifestations between patients with different classes of mutations.
Koch C; Cuppens H; Rainisio M; Madessani U; Harms H; Hodson M; Mastella G; Navarro J; Strandvik B; McKenzie S;
Pediatr Pulmonol; 2001 Jan; 31(1):1-12. PubMed ID: 11180668
[TBL] [Abstract][Full Text] [Related]
13. Early Childhood Risk Factors for Decreased FEV1 at Age Six to Seven Years in Young Children with Cystic Fibrosis.
Sanders DB; Emerson J; Ren CL; Schechter MS; Gibson RL; Morgan W; Rosenfeld M;
Ann Am Thorac Soc; 2015 Aug; 12(8):1170-6. PubMed ID: 26288390
[TBL] [Abstract][Full Text] [Related]
14. Longevity of patients with cystic fibrosis in 2000 to 2010 and beyond: survival analysis of the Cystic Fibrosis Foundation patient registry.
MacKenzie T; Gifford AH; Sabadosa KA; Quinton HB; Knapp EA; Goss CH; Marshall BC
Ann Intern Med; 2014 Aug; 161(4):233-41. PubMed ID: 25133359
[TBL] [Abstract][Full Text] [Related]
15. Gaps in Cystic Fibrosis Care Are Associated with Reduced Lung Function in the U.S. Cystic Fibrosis Foundation Patient Registry.
Sears EH; Hinton AC; Lopez-Pintado S; Lary CW; Zuckerman JB
Ann Am Thorac Soc; 2023 Sep; 20(9):1250-1257. PubMed ID: 37027571
[No Abstract] [Full Text] [Related]
16. Cystic fibrosis transmembrane conductance regulator (CFTR)-mediated residual chloride secretion does not protect against early chronic Pseudomonas aeruginosa infection in F508del homozygous cystic fibrosis patients.
Derichs N; Mekus F; Bronsveld I; Bijman J; Veeze HJ; von der Hardt H; Tummler B; Ballmann M
Pediatr Res; 2004 Jan; 55(1):69-75. PubMed ID: 14605249
[TBL] [Abstract][Full Text] [Related]
17. Pseudomonas aeruginosa and other predictors of mortality and morbidity in young children with cystic fibrosis.
Emerson J; Rosenfeld M; McNamara S; Ramsey B; Gibson RL
Pediatr Pulmonol; 2002 Aug; 34(2):91-100. PubMed ID: 12112774
[TBL] [Abstract][Full Text] [Related]
18. [Italian Cystic Fibrosis Registry. Report 2011-2014].
Giordani B; Amato A; Majo F; Ferrari G; Quattrucci S; Minicucci L; Padoan R; Floridia G; Puppo Fornaro G; Taruscio D; Salvatore M;
Epidemiol Prev; 2018; 42(1S1):1-32. PubMed ID: 29506377
[TBL] [Abstract][Full Text] [Related]
19. IL8 gene as modifier of cystic fibrosis: unraveling the factors which influence clinical variability.
Furlan LL; Marson FA; Ribeiro JD; Bertuzzo CS; Salomão Junior JB; Souza DR
Hum Genet; 2016 Aug; 135(8):881-94. PubMed ID: 27209008
[TBL] [Abstract][Full Text] [Related]
20. Risk factors for age at initial Pseudomonas acquisition in the cystic fibrosis epic observational cohort.
Rosenfeld M; Emerson J; McNamara S; Thompson V; Ramsey BW; Morgan W; Gibson RL;
J Cyst Fibros; 2012 Sep; 11(5):446-53. PubMed ID: 22554417
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
